Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Net Cash Flow (2023 - 2026)

Cannabis Bioscience International Holdings' Net Cash Flow history spans 4 years, with the latest figure at -$14597.0 for Q1 2026.

  • On a quarterly basis, Net Cash Flow fell 3115.2% to -$14597.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$111398.0, a 45183.74% decrease, with the full-year FY2025 number at $12197.0, up 249.51% from a year prior.
  • Net Cash Flow hit -$14597.0 in Q1 2026 for Cannabis Bioscience International Holdings, down from -$5493.0 in the prior quarter.
  • Over the last five years, Net Cash Flow for CBIH hit a ceiling of $12404.0 in Q2 2025 and a floor of -$103712.0 in Q3 2025.
  • Historically, Net Cash Flow has averaged -$10379.9 across 4 years, with a median of -$454.0 in 2025.
  • The widest YoY moves for Net Cash Flow: up 31905.13% in 2025, down 48563.55% in 2025.
  • Tracing CBIH's Net Cash Flow over 4 years: stood at -$4410.0 in 2023, then surged by 100.75% to $33.0 in 2024, then plummeted by 16745.45% to -$5493.0 in 2025, then plummeted by 165.74% to -$14597.0 in 2026.
  • Business Quant data shows Net Cash Flow for CBIH at -$14597.0 in Q1 2026, -$5493.0 in Q4 2025, and -$103712.0 in Q3 2025.